⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22446495 | 0.63 | NOTUM (0.50) | — | |
| SCHEMBL22556219 | 0.61 | NPC1 (0.33) | — | |
| Hydrochloric Acid SCHEMBL27555391 | 0.60 | — | — | |
| SCHEMBL22770163 | 0.60 | NOTUM (0.35) | — | |
| SCHEMBL27696 | 0.56 | — | — | |
| SCHEMBL12020221 | 0.51 | — | — | |
| SCHEMBL12590 | 0.51 | — | — | |
| Hydrochloric Acid SCHEMBL6216888 | 0.48 | — | — | |
| Hydrochloric Acid SCHEMBL27387126 | 0.43 | — | — | |
| SCHEMBL28031735 | 0.43 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4722192-A1 | PROCESS FOR THE PREPARATION OF AMIDE INTERMEDIATES | Adama Agan Ltd. (IL) | 2026-04-08 | — | — | EP | claimed |
| US-20240287008-A1 | METHOD FOR THE SYNTHESIS OF 3-R-1,4,2-DIOXAZOL-5-ONES | PANASONIC HOLDINGS CORPORATION (JP) | 2024-08-29 | — | — | US | claimed |
| US-11981648-B2 | Method for the synthesis of 3-R-1,4,2-dioxazol-5-ones | TESLA, INC. (US) | 2024-05-14 | — | — | US | claimed |
| CN-117736204-A | Preparation method of N- (2-acetamidophenyl) -7-azaindole | 青岛科技大学 | 2024-03-22 | — | — | CN | claimed |
| US-20230029852-A1 | METHOD FOR THE SYNTHESIS OF 3-R-1,4,2-DIOXAZOL-5-ONES | PANASONIC HOLDINGS CORPORATION (JP) | 2023-02-02 | — | — | US | claimed |
| CN-111689926-B | Preparation method, product and application of 3-methyl-1, 4, 2-dioxazole-5-ketone | 江苏华盛锂电材料股份有限公司 | 2022-04-12 | — | — | CN | claimed |
| US-20200392091-A1 | METHOD FOR THE SYNTHESIS OF 3-R-1,4,2-DIOXAZOL-5-ONES TECHNICAL FIELD | Tesla Motors Canada ULC (CA) | 2020-12-17 | — | — | US | claimed |
| CN-111689926-A | Preparation method, product and application of 3-methyl-1, 4, 2-dioxazole-5-ketone | 江苏华盛锂电材料股份有限公司 | 2020-09-22 | — | — | CN | claimed |
| US-20260137795-A1 | EXATECAN IMMUNOCONJUGATES | IMMUNOME INC (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4722192-A1 | PROCESS FOR THE PREPARATION OF AMIDE INTERMEDIATES | Adama Agan Ltd. (IL) | 2026-04-08 | — | — | EP | disclosed |
| EP-4655006-A2 | EXATECAN IMMUNOCONJUGATES | Immunome, Inc. (US) | 2025-12-03 | — | — | EP | disclosed |
| CN-120271463-A | Lignin-derived acetaminophen compound and synthesis method thereof | 福建农林大学 | 2025-07-08 | — | — | CN | disclosed |
| CN-119977829-A | Quick synthesis method of beta-amino acid derivative | 华南理工大学 | 2025-05-13 | — | — | CN | disclosed |
| CN-119816953-A | High cycle life lithium ion battery cell with nanostructured silicon-containing anode | 莱顿瓶科技私人有限责任公司 | 2025-04-11 | — | — | CN | disclosed |
| US-20140179648-A1 | Novel Heterocyclic Compounds as Bromodomain Inhibitors | RVX THERAPEUTICS INC. (CA) | 2014-06-26 | — | — | US | disclosed |
| US-7977331-B1 | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor | JAPAN TOBACCO INC. (JP) | 2011-07-12 | — | — | US | disclosed |
| US-7977331-B1 | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor | JAPAN TOBACCO INC. (JP) | 2011-07-12 | — | — | US | disclosed |
| EP-1636216-B1 | BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2010-07-21 | — | — | EP | disclosed |
| US-7285551-B2 | Fused-ring compounds and use thereof as drugs | JAPAN TOBACCO INC. (JP) | 2007-10-23 | — | — | US | disclosed |
| US-7285551-B2 | Fused-ring compounds and use thereof as drugs | JAPAN TOBACCO INC. (JP) | 2007-10-23 | — | — | US | disclosed |